Caudal Versus S1 Transforaminal Epidural Steroid Injection for the Treatment of Unilateral S1 Radiculopathy

Sponsor
Istanbul Medeniyet University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05711121
Collaborator
Marmara University (Other)
60
1
2
5.2
11.6

Study Details

Study Description

Brief Summary

To compare the efficacies of two different interventional techniques (Caudal epidural steroid injection and S1 transforaminal epidural steroid injection) for the treatment of unilateral S1 radiculopathy.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Transforaminal epidural steroid injection
  • Procedure: Caudal epidural steroid injection
N/A

Detailed Description

Epidural steroid injections are commonly performed for the treatment of radicular pain resulting from a disc herniation. There are 3 different methods to deliver steroids to epidural area which are caudal, interlaminar and transforaminal routes. Lower lumbar and sacral radiculopathies can be managed with caudal epidural steroid injection which is generally quite easier to perform in comparison to transforaminal injection. Transforaminal epidural injection provides injectate to reach anterior epidural area and is the most target specific technique among others. In the present study investigators aim is to compare the success rates of these two different procedures regarding unilateral S1 radiculopathy. The patients referring to the pain medicine outpatient clinic of a university hospital for unilateral radicular pain and diagnosed S1 radiculopathy were planned to be randomized into these two different intervention groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients having radicular pain were randomized to either caudal or transforaminal epidural injection groupPatients having radicular pain were randomized to either caudal or transforaminal epidural injection group
Masking:
Double (Participant, Investigator)
Masking Description:
Patients and the investigator assessing the treatment results were blinded to the injection technique.
Primary Purpose:
Treatment
Official Title:
Caudal Versus S1 Transforaminal Epidural Steroid Injection for the Treatment of Unilateral S1 Radiculopathy
Actual Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Jun 28, 2023
Anticipated Study Completion Date :
Jul 8, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: S1 transforaminal

The group receiving S1 transforaminal epidural steroid injection

Procedure: Transforaminal epidural steroid injection
Fluoroscopy-guided transforaminal epidural injection for radicular pain resulting from a disc herniation.

Active Comparator: Caudal

The group receiving caudal epidural steroid injection

Procedure: Caudal epidural steroid injection
Fluoroscopy-guided caudal epidural injection for radicular pain resulting from a disc herniation.

Outcome Measures

Primary Outcome Measures

  1. 50 percent pain relief [3 months]

    Number of patients having at least 50 percent pain relief

Secondary Outcome Measures

  1. Oswestry Disability Index [3 months]

    Improvement in disability scores, 0 is the best, 100 is the worst score.

  2. Procedure time [during procedure]

    The overall ease of application regarding procedure time.

  3. Radiation exposure [during procedure]

    The exposed radiation dose during the procedures

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Unilateral radicular pain resulting from a paracentral L5-S1 disc herniation causing S1 nerve root compression.
Exclusion Criteria:
  • History of previous surgery, pregnancy, neurological disorders, bleeding diathesis, contrast medium allergy, spinal disorders, rheumatologic diseases

Contacts and Locations

Locations

Site City State Country Postal Code
1 Marmara University School of Medicine Istanbul Pendik Turkey 34899

Sponsors and Collaborators

  • Istanbul Medeniyet University
  • Marmara University

Investigators

  • Study Director: Osman Hakan Gunduz, Prof., Marmara University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bilinç Doğruöz Karatekin, Bilinc Dugruoz Karatekin, M.D., Department of Physical Medicine and Rehabilitation, Istanbul Medeniyet University
ClinicalTrials.gov Identifier:
NCT05711121
Other Study ID Numbers:
  • 09.2020.719
First Posted:
Feb 2, 2023
Last Update Posted:
Feb 2, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bilinç Doğruöz Karatekin, Bilinc Dugruoz Karatekin, M.D., Department of Physical Medicine and Rehabilitation, Istanbul Medeniyet University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 2, 2023